Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Schaberg

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Biochemical and Biophysical Research Communications|June 14, 1991
Evidence for a platelet-activating factor receptor on human alveolar macrophagesT Schaberg, H Haller, H Lode
Pneumologie (Stuttgart, Germany)|April 1, 1996
[New developments in non-tuberculoid mycobacterioses. 1: Diseases in patients without HIV infection]N Schönfeld, T Schaberg, R Loddenkemper
Deutsche Medizinische Wochenschrift (1946)|February 2, 1996
[Therapy of lung abscesses]T Schülin, T Schaberg, H Lode
Der Internist|June 1, 1992
[Chemotherapeutic prevention of infection in invasive interventions in high-risk internal medicine patients]H Lode, T Schaberg, G Höffken
Deutsche Medizinische Wochenschrift (1946)|October 30, 1992
[The clinical picture and diagnosis of pulmonary mycoses]T Schaberg, H Mauch, H Lode
Pneumologie (Stuttgart, Germany)|August 31, 2007
[Emergence extensive drug resistance tuberculosis (XDR)]H Vier, T Schaberg, A Gillissen
The European Respiratory Journal|September 2, 2005
Cost-effectiveness of isoniazid chemoprevention in close contactsR Diel, A Nienhaus, T Schaberg
Chest|January 1, 1997
Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?R Erbes, T Schaberg, R Loddenkemper
Infection|May 1, 1995
Selective decontamination of the digestive tract: indications and problemsH Lode, T Schaberg, R Stahlmann
Pneumologie (Stuttgart, Germany)|May 14, 2015
[Non Tuberculous Mycobacteria--a Short Review about Epidemiology, Diagnosis and Treatment]L Bös, N Schönfeld, T Schaberg
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Biochemical and Biophysical Research Communications|June 14, 1991
Evidence for a platelet-activating factor receptor on human alveolar macrophagesT Schaberg, H Haller, H Lode
Pneumologie (Stuttgart, Germany)|April 1, 1996
[New developments in non-tuberculoid mycobacterioses. 1: Diseases in patients without HIV infection]N Schönfeld, T Schaberg, R Loddenkemper
Deutsche Medizinische Wochenschrift (1946)|February 2, 1996
[Therapy of lung abscesses]T Schülin, T Schaberg, H Lode
Der Internist|June 1, 1992
[Chemotherapeutic prevention of infection in invasive interventions in high-risk internal medicine patients]H Lode, T Schaberg, G Höffken
Deutsche Medizinische Wochenschrift (1946)|October 30, 1992
[The clinical picture and diagnosis of pulmonary mycoses]T Schaberg, H Mauch, H Lode
Pneumologie (Stuttgart, Germany)|August 31, 2007
[Emergence extensive drug resistance tuberculosis (XDR)]H Vier, T Schaberg, A Gillissen
The European Respiratory Journal|September 2, 2005
Cost-effectiveness of isoniazid chemoprevention in close contactsR Diel, A Nienhaus, T Schaberg
Chest|January 1, 1997
Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome?R Erbes, T Schaberg, R Loddenkemper
Infection|May 1, 1995
Selective decontamination of the digestive tract: indications and problemsH Lode, T Schaberg, R Stahlmann
Pneumologie (Stuttgart, Germany)|May 14, 2015
[Non Tuberculous Mycobacteria--a Short Review about Epidemiology, Diagnosis and Treatment]L Bös, N Schönfeld, T Schaberg
Pageof 18